Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis

Bethany R. Collier (Editor)

Series: Obstetrics and Gynecology Advances
BISAC: MED033000

Clear

$255.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Ovarian cancer is the third most diagnosed gynecologic cancer and the first leading cause of death from all of gynecological malignancies. High mortality of the patients is usually associated with the progression of the disease. Most patients are diagnosed within the advanced stages due to lacking relevant diagnostic and screening markers. This handbook discusses several risk factors of ovarian cancer. It also examines the different therapies provided to ovarian cancer patients, and the prognosis of the cancer.
(Imprint: Nova Biomedical)

Preface

Chapter 1
Risk Factors in Ovarian Cancer: A Brief Overview
(Ludek Zavesky, Eva Jandakova and Radovan Turyna, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University Prague and General University Hospital in Prague, Albertov, Prague, the Czech Republic, and others)

Chapter 2
Ovarian Cancer: New Therapies, Potential Risk Factors and Prognostic Values for Improving Survival Outcomes in Women
(Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva, João Paulo de Arruda Amorim, and Luiz Antonio Lupi Júnior, Department of Anatomy - IBB/UNESP, Institute of Biosciences of Botucatu, Univ. Estadual Paulista, SP, Brazil, and others)

Chapter 3
MicroRNAs in Diagnosis of Ovarian Cancer. Potential, Challenges, Pitfalls
(Ludek Zavesky, Eva Jandakova, Lucie Langmeierova, Vit Weinberger and Lubos Minar, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague and General University Hospital in Prague, Albertov, Prague, the Czech Republic, and others)

Chapter 4
Immunotherapy and Target Therapy: New Approaches in Ovarian Cancer
(Rosekeila Simões Nomelini, Millena Prata Jammal, Agrimaldo Martins Filho and Eddie Fernando Candido Murta, Discipline of Gynecology and Obstetrics, Oncological Research Institute (IPON), Federal University of the Triângulo Mineiro, Uberaba – MG, Brazil)

Chapter 5
Dopamine Receptor: A Treatment Target for Ovarian Cancer
(Min Yong, Jinyan Li, Lina Hu and Tinghe Yu, Key Medical Laboratory of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China)

Chapter 6
Malignant Ovarian Germ Cell Tumors: Treatment and Prognosis
(Díaz-Murillo R, Lombarte-García M, de Santiago J, Zapardiel I., Gynecologic Oncology Unit. La Paz University Hospital-IdiPAZ. Madrid, Spain)

Chapter 7
Controversies in the Management of Ovarian Cancer
(Grace Hwei Ching Tan, Melissa Ching Ching Teo, Associate Consultant, Division of Surgical Oncology, National Cancer Centre Singapore, and others)

Chapter 8
Splenectomy as Part of Cytoreductive Surgery for Advanced Stage and Relapsed Ovarian Cancer
(N. Bacalbasa, and Irina Balescu, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Ponderas Hospital, Bucharest, Romania)

Chapter 9
Liver Surgery in Ovarian Cancer Liver Metastases
(N. Bacalbasa, and Irina Balescu, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Ponderas Hospital, Bucharest, Romania)

Chapter 10
Potential of Phytochemicals and their Derivatives in the Treatment of Ovarian Cancer
(Wen-Wu Li, Okiemute R. Johnson-Ajinwo, and Fidelia I. Uche, Institute for Science and Technology in Medicine, Keele University, UK)

Chapter 11
Molecular Alterations Chemoresistance-Related in Ovarian Cancer Patients and Related Target Therapies
(Lucrezia Amoroso, Francesca De Iuliis and Susanna Scarpa, Experimental Medicine Department, Sapienza University of Rome, Italy)

Chapter 12
Primary Cytoreduction in Ephitelial Ovarian Cancer
(Elsa Delgado-Sánchez, María Martín-Cameán, Ignacio Zapardiel, Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain)

Chapter 13
Sensitizing Chemotherapy with Ultrasound
(Li Luo, Jinyan Li, Meijiao Wang, Lin Yu and Tinghe Yu, Key Medical Laboratory of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China, and others)

Chapter 14
Elderly Ovarian Cancer Patients: Treatment Options
(Francesca De Iuliis, Lucrezia Amoroso and Susanna Scarpa, Experimental Medicine Department, Sapienza University of Rome, Italy)

Index

You have not viewed any product yet.